Author:
Liu Han,Lei Lin,Song Song,Geng Xianyi,Lin Kaihao,Li Ni,Chen Wanqing,Peng Ji,Ren Jiansong
Funder
Sanming Project of Medicine in Shenzhen
Shenzhen Science and Technology Innovation Program
National Key R&D Program of China
National Science & Technology Fundamental Resources Investigation Program of China
Publisher
Springer Science and Business Media LLC
Reference87 articles.
1. Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;4:1–35.
2. Wei X, Yu S, Wang J, Xiang Z, Liu L, Min Y. Association between time from diagnosis to treatment and survival of patients with nasopharyngeal carcinoma: a population-based cohort study. Curr Probl Cancer. 2024;48:101060.
3. Koide Y, Kodaira T, Kitayama M, Kawakita D, Kirita T, Yoshimoto S, et al. Definitive radiotherapy for nasopharyngeal carcinoma in Japan: analysis of cases in the National Head and Neck Cancer Registry from 2011 to 2014. Jpn J Clin Oncol. 2024;54(1):54–61.
4. Huang J, Yang Z-Y, Wu B, Ding Q, Qin Y, Zhang Z-J, et al. Long-term therapeutic outcome and prognostic factors of patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy: an analysis of 608 patients from low-endemic regions of China. Curr Med Sci. 2021;41(4):737–45.
5. Xu M, Zang J, Luo S, Wang J, Li X. Long-term survival outcomes and adverse effects of nasopharyngeal carcinoma patients treated with IMRT in a non-endemic region: a population-based retrospective study. BMJ Open. 2021;11(8):e045417.